Literature DB >> 23888639

Reducing Clostridium difficile incidence, colectomies, and mortality in the hospital setting: a successful multidisciplinary approach.

Leonard A Mermel1, Julie Jefferson, Kerry Blanchard, Stephen Parenteau, Benjamin Mathis, Kimberle Chapin, Jason T Machan.   

Abstract

BACKGROUND: Health care associated Clostridium difficile infections are a major cause of morbidity and mortality in hospitals. In the United States, from 2000 through 2009, discharge diagnoses from hospitals in the United States that included C. difficile increased from 139,000 to 336,600, and the yearly national excess hospital cost associated with hospital-onset C. difficile is estimated to be upwards of $1.3 billion.
METHODS: A hospitalwide, multidisciplinary approach was undertaken at Rhode Island Hospital (Providence), a tertiary care hospital. The hospital plan entailed six interventions: (1) develop a C. difficile hospital infection control plan based on a risk assessment; (2) monitor hospitalwide morbidity and mortality associated with C. difficile infection; (3) improve sensitivity of C. difficile toxin detection in stool specimens using a polymerase chain reaction-based nucleic acid amplification assay; (4) enhance environmental cleaning of patient rooms and equipment; (5) develop a C. difficile infection treatment plan; and (6) conduct other interventions. The incidence of health care-associated C. difficile infection was assessed from January 2006 through the third quarter of 2012; the number of colectomies and mortality associated with C. difficile infection were determined from January 2005 through the third quarter of 2012.
RESULTS: The incidence of health care-associated C. difficile infection decreased from a peak of 12.2/1,000 discharges during the second quarter of 2006 to 3.6/1,000 discharges during the third quarter of 2012. The yearly mortality in patients with health care-associated C. difficile infection was reduced from a peak of 52 in 2006 to 19 in 2011, with 13 such cases in the first three quarters of 2012.
CONCLUSIONS: A hospitalwide multidisciplinary approach can reduce health care-associated C. difficile infection morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23888639     DOI: 10.1016/s1553-7250(13)39042-4

Source DB:  PubMed          Journal:  Jt Comm J Qual Patient Saf        ISSN: 1553-7250


  7 in total

1.  Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?

Authors:  Ferric C Fang; Christopher R Polage; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2017-01-11       Impact factor: 5.948

Review 2.  Reducing Clostridium difficile in the Inpatient Setting: A Systematic Review of the Adherence to and Effectiveness of C. difficile Prevention Bundles.

Authors:  Anna K Barker; Caitlyn Ngam; Jackson S Musuuza; Valerie M Vaughn; Nasia Safdar
Journal:  Infect Control Hosp Epidemiol       Date:  2017-03-27       Impact factor: 3.254

3.  Effectiveness of various cleaning and disinfectant products on Clostridium difficile spores of PCR ribotypes 010, 014 and 027.

Authors:  N Kenters; E G W Huijskens; S C J de Wit; I G J M Sanders; J van Rosmalen; E J Kuijper; A Voss
Journal:  Antimicrob Resist Infect Control       Date:  2017-06-03       Impact factor: 4.887

4.  A mathematical model of Clostridium difficile transmission in medical wards and a cost-effectiveness analysis comparing different strategies for laboratory diagnosis and patient isolation.

Authors:  Vered Schechner; Yehuda Carmeli; Moshe Leshno
Journal:  PLoS One       Date:  2017-02-10       Impact factor: 3.240

5.  Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations.

Authors:  Julie Storr; Anthony Twyman; Walter Zingg; Nizam Damani; Claire Kilpatrick; Jacqui Reilly; Lesley Price; Matthias Egger; M Lindsay Grayson; Edward Kelley; Benedetta Allegranzi
Journal:  Antimicrob Resist Infect Control       Date:  2017-01-10       Impact factor: 4.887

6.  Reducing rates of Clostridium difficile infection by switching to a stand-alone NAAT with clear sampling criteria.

Authors:  E Casari; C De Luca; M Calabrò; C Scuderi; C Daleno; A Ferrario
Journal:  Antimicrob Resist Infect Control       Date:  2018-03-12       Impact factor: 4.887

7.  National epidemiology of initial and recurrent Clostridium difficile infection in the Veterans Health Administration from 2003 to 2014.

Authors:  Kelly R Reveles; Kenneth A Lawson; Eric M Mortensen; Mary Jo V Pugh; Jim M Koeller; Jacqueline R Argamany; Christopher R Frei
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.